Literature DB >> 18505773

Seronegative neuromyelitis optica: improvement following lymphocytapheresis treatment.

E Moreh, I Gartsman, D Karussis, D Rund, N Hiller, Z Meiner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18505773     DOI： 10.1177/1352458508088943

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  5 in total

1.  Neuromyelitis optica - an update: 2007-2009.

Authors:  Anu Jacob
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

2.  Anti-aquaporin-4 antibodies in Devic's neuromyelitis optica: therapeutic implications.

Authors:  Romain Marignier; Pascale Giraudon; Sandra Vukusic; Christian Confavreux; Jérôme Honnorat
Journal:  Ther Adv Neurol Disord       Date:  2010-09       Impact factor: 6.570

3.  Current and future treatment approaches for neuromyelitis optica.

Authors:  Nicolas Collongues; Jérôme de Seze
Journal:  Ther Adv Neurol Disord       Date:  2011-03       Impact factor: 6.570

4.  Effectiveness of multi-disciplinary rehabilitation for patients with Neuromyelitis Optica.

Authors:  Yael Nechemia; Elior Moreh; Harold Weingarden; Ayala Bloch; Uri Givon; Adi Vaknin-Dembinsky; Isabella Schwartz; Zeev Meiner; Gabi Zeilig
Journal:  J Spinal Cord Med       Date:  2016-03-24       Impact factor: 1.985

5.  Plasma exchange in severe attacks of neuromyelitis optica.

Authors:  Mickael Bonnan; Philippe Cabre
Journal:  Mult Scler Int       Date:  2012-02-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.